In recent years much interest has focused on the development of appropriate carrier delivery systems whereby drugs, enzymes and other agents might be directed to specific tissues and subcellular sites thereby improving their therapeutic activity and decreasing secondary site effects.
Liposomes have been proposed as potential carriers since chemicals can be entrapped within their structure and they are taken up by tissues, particularly the liver and spleen, and they are biodegradable. Agents which have been successfully incorporated into liposomes include amyloglucosidase (Gregoriadis et al., 1971) , invertase (Gregoriadis & Buckland, 1973) , EDTA (Rahman et al., 1973) , actinomycin D (Rahman et al., 1974) and methotrexate (Colley & Ryman, 1975) . We have been investigating the use of liposomes as carriers of agents to protect against drug-induced liver damage in mice, using glutathione as the protective agent. Large doses of paracetamol produce in mice a well-defined hepatic necrosis which appears to be related to depletion of the liver glutathione (Mitchell et al., 1973a,b) .
Male Swiss-strain albino mice (25 g body weight), injected intraperitoneally with paracetamol(500mg/kg) dissolved in 0.9% NaCI, developed liver necrosis as was shown by the large increase after 24h in plasma aspartate aminotransferase (glutamate-oxaloacetate transaminase) and alanine aminotransferase (glutamatepyruvate transaminase) activities as well as the index of necrosis (Table 1) . For the latter, four degrees of severity of liver damage were distinguished on the basis of histopathological examination and these were graded as follows: slight focal necrosis, 1 ; clear focal necrosis, 2; extensive focal or zonal necrosis, 3; massive necrosis, 4. The mean of the scores for a group of ten or more mice gave the necrosis index.
The administration of four doses of glutathione each of 128mg/kg at 15,45, 75 and 105 min after the paracetamol, significantly protected against the hepatotoxic effects of the latter, as shown by the much lower activities of the plasma transaminases and the given intravenously 15min after the paracetamol were largely effective in protecting against the hepatoxicity of the latter. Separate experiments showed that only 9-1 1 % of an intravenously injected dose of [l4C1glutathione was taken up by the mouse liver and it was thought that this uptake might be improved by incorporating the glutathione into liposomes which are known to accumulate in the liver (Gregoriadis & Ryman, 1972; Rahman et al., 1973) . Glutathione entrapped in liposomes was prepared as follows: [gly~yf-'~C]glutathione (900mg; 2pCi) was dissolved in buffer, pH 7.6, (composition : 10m~-Tris-l0m~-HCI-l5Om~-NaCl), phosphatidylcholine (200mg) was added and the suspension was sonicated under N2 in a sonifier (70W; frequency 17kHz) for 2min. The non-entrapped glutathione was removed by ultrafiltration and the glutathione content of the liposomes was calculated from the specific radioactivity of the liposomal preparation. Incorporation of [14C]glutathione was 5-8 % of the total glutathione and the ratio phosphatidylcholine/glutathione was about 4.
Expt. 3 shows that glutathione entrapped in liposomes was much less effective than the free drug in decreasing the hepatotoxic effects of paracetamol. Thus the plasma transaminase values and the index of necrosis for the group of mice treated with encapsulated glutathione were very similar to the values found for the group treated with paracetamol alone. The administration of non-entrapped glutathione significantly countered the hepatotoxic effects of paracetamol.
Other work on phagocytosis of liposomes in vitro by mouse peritoneal macrophages followed by electron microscopy of the cells showed that breakdown of the liposomes occurs 1-2h after their uptake (G. Auderset, L. Kreber, A. Louis, M. Strolin Benedetti, A. Malnoe & M. Schneider, unpublished work). The failure of the glutathioneentrapped in liposomes to protect against paracetamol-induced liver damage may therefore be due to a too slow pattern of release. This possibility was investigated in Expt. 4 by injecting, intravenously, liposomes containing glutathione as four separate doses at 15,45,75 and 105min before the paracetamol. This treatment failed to give significant protection. It should be noted that glutathione itself is much less effective as a protective agent if given before rather than after the paracetamol (Expt. 1).
The findings suggest that the incorporation of glutathione into phosphatidylcholine liposomes decreases its effectiveness in protecting against paracetamol-induced liver damage. This may be due to breakdown of the compound in the lysosomes after its release or an unfavourable release pattern.
